The global Drug Discovery Software market valued at ~$2 billion in Next five years and is expected to grow at a CAGR of ~14% to cross $3.5 billion by 2025, driven by growing R&D spending across the world, need for cost-efficiency & faster time-to-market, stringent regulatory compli